TrialCancer medicine2021

Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China.

Zhitao Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.